In November, the BSEC requested the finance ministry and the National Board of Revenue for a five year tax holiday to ...

Capital Infra Trust's ₹1,578-crore IPO for infrastructure assets, with anchor investors and road projects, closes on January ...

Positive market feedback has generated significant interest, with shares trading at a ₹97 premium in the grey market.

(Reuters) - Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of ...

Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.

Pace at which PEs are leaning into India, Japan and ANZ is striking, said top Asian dealmaker. Global capital according to ...

Spanish travel technology company HBX Group, whose brands include Hotelbeds, is preparing to launch a 1 billion Euro ($1.04 billion) initial public offering in coming weeks, two people familiar with ...

Capital Infra Trust’s IPO of ₹1,578 crore opened for subscription today, January 7 and will end on Janaury 9, with shares ...

The healthcare company began trading publicly on Tuesday and rose 15 per cent on debut as it hovered around the SAR139.60 ...

While many will paint AI as the magic bullet for banking in 2025, we must remember that sound investments require careful ...

Barclays Plc’s Stephen Dainton is preparing for a wave of dealmaking this year as more US companies have been buoyed by ...

The IPO garnered widespread interest from local, regional, and international investors, with an oversubscription rate of 103x ...